Fed Circuit Watch: Dietary Supplement Claims Found Patent-Eligible
In its second patent-eligibility ruling in a few weeks, the Court of Appeals for the Federal Circuit decided Natural Alts. Int’l, Inc. v. Creative Compounds, LLC, on March 15, 2019, in which it found...
TechPat: U.S. Patent No. D835,564
U.S. Patent No. D835,564 S (‘564) issued on December 11, 2018, for “Wiper.” It was issued to inventors Franz Von Holzhausen of Malibu, California, David Tadashi Imai of Los Angeles, California,...
Fed Circuit Watch: No Standing to Appeal When Biosimilar Product Withdrawn
Sometimes substantive patent issues are never dealt with in cases, but rather dispositive issues are handled by procedural mechanisms. One case in point is Momenta Pharms., Inc. v. Bristol-Myers...
Fed Circuit Watch: Party Lacks Both Sovereign Immunity and Patent-Eligible Treatment Claims
In one of the more fascinating legal analyses presented in recent memory, the Court of Appeals for the Federal Circuit handed down Univ. of Florida Res. Foundation, Inc. v. General Electric Co., on...
TechPat: U.S. Patent No. 10,109,003 B1
U.S. Patent No. 10,109,003 B1 (‘003), issued on October 23, 2018, for “Method, Medium, and System for Enhancing Privacy.” The inventors are Jon Jenkins of San Francisco, and Catherine Cissy Lee of...
TechPat: U.S. Patent No. 10,227,611 B2
Today is DNA Day, and to honor the occasion, we present a newly issued patent utilizing deoxyribonucleic acid, or DNA. U.S. Patent No. 10,227,611 B2 (‘611) issued on March 12, 2019, for “Methods and...
CannabIP: U.S. Patent No. 10,098,867 B2
U.S. Patent No. 10,098,867 B2 (‘867) issued on October 16, 2018, for “Use of Phytocannabinoids in the Treatment of Ovarian Carcinoma.” It was issued to applicant GW Research Ltd. of Cambridge, Great...
TechPat: U.S. Patent No. 10,152,892 B2
U.S. Patent No. 10,152,892 B2 (‘892), issued on December 11, 2018, for “Autonomous Vehicle Notification System.” The inventors are Taggart Matthiesen of Kentfield, California, Jisi Guo of San...
CannabIP: U.S. Patent No. 10,137,161 B2
U.S. Patent No. 10,137,161 B2 (‘161) issued on November 27, 2018, for “Medical Cannabis Lozenges and Compositions Thereof.” It was issued to applicant/inventor Jeffrey A. Kolsky of San Francisco,...
SCOTUS Watch: Costs Recovered Limited as Specified in Copyright Act
In the second copyright case decided by the U.S. Supreme Court on March 4, 2019, Rimini Street, Inc. v. Oracle USA, Inc., the high court dealt with the question of whether “full costs” is more than...
No posts found
Try adjusting your filters